Pharmaids Pharmaceuticals Ltd Financial Ratios
PHARMAIDSPHARMACEUTICALSLTD · Healthcare · Current price
P/E ratio
-24.1x
P/B ratio
2.2x
ROE
-26.5%
ROCE
-18.5%
Debt / Equity
0.49
Dividend yield
0.0%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | -24.1x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 2.2x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | -26.5% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | -18.5% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 0.49 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with Pharmaids Pharmaceuticals Ltd's latest numbers.
Pharmaids Pharmaceuticals Ltd profitability
Pharmaids Pharmaceuticals Ltd generates a return on equity of -26.5% and a return on capital employed of -18.5%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 0.49 and a P/E of -24.1x, Pharmaids Pharmaceuticals Ltd is conservatively financed. Our overall business-quality score for the company is 3.0 / 10.
Understand the ratios
More on Pharmaids Pharmaceuticals Ltd
DocStoX estimates are computed from reported financials, for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.